Annual EBITDA
$39.09 M
+$44.71 M+794.90%
December 31, 2022
Summary
- As of February 10, 2025, SELB annual EBITDA is $39.09 million, with the most recent change of +$44.71 million (+794.90%) on December 31, 2022.
- During the last 3 years, SELB annual EBITDA has risen by +$92.19 million (+173.61%).
Performance
SELB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$12.62 M
-$2.16 M-20.69%
September 30, 2023
Summary
- As of February 10, 2025, SELB quarterly EBITDA is -$12.62 million, with the most recent change of -$2.16 million (-20.69%) on September 30, 2023.
- Over the past year, SELB quarterly EBITDA has dropped by -$5.56 million (-78.75%).
Performance
SELB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$37.08 M
-$5.56 M-17.64%
September 30, 2023
Summary
- As of February 10, 2025, SELB TTM EBITDA is -$37.08 million, with the most recent change of -$5.56 million (-17.64%) on September 30, 2023.
- Over the past year, SELB TTM EBITDA has dropped by -$83.00 million (-180.74%).
Performance
SELB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SELB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +794.9% | -78.8% | -180.7% |
| 3 y3 years | +173.6% | -36.8% | +44.2% |
| 5 y5 years | +161.7% | +18.1% | +30.2% |
SELB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -114.4% | -142.3% | +63.6% | -171.3% | at low |
| 5 y | 5-year | at high | -270.3% | -142.3% | +88.2% | -171.3% | +91.9% |
| alltime | all time | at high | -270.3% | -142.3% | +88.2% | -171.3% | +91.9% |
Selecta Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$12.62 M(+20.7%) | -$37.08 M(+17.6%) |
| Jun 2023 | - | -$10.46 M(-49.3%) | -$31.52 M(+176.5%) |
| Mar 2023 | - | -$20.65 M(-410.4%) | -$11.40 M(-129.2%) |
| Dec 2022 | $39.09 M(-794.9%) | $6.65 M(-194.2%) | $39.09 M(-14.9%) |
| Sep 2022 | - | -$7.06 M(-173.1%) | $45.92 M(-11.6%) |
| Jun 2022 | - | $9.66 M(-67.6%) | $51.97 M(+8.5%) |
| Mar 2022 | - | $29.84 M(+121.2%) | $47.89 M(-951.4%) |
| Dec 2021 | -$5.63 M(-91.6%) | $13.49 M(-1427.7%) | -$5.63 M(-83.3%) |
| Sep 2021 | - | -$1.02 M(-118.2%) | -$33.60 M(-19.6%) |
| Jun 2021 | - | $5.58 M(-123.6%) | -$41.82 M(-41.2%) |
| Mar 2021 | - | -$23.68 M(+63.4%) | -$71.15 M(+6.9%) |
| Dec 2020 | -$66.59 M(+25.4%) | -$14.49 M(+57.0%) | -$66.59 M(+0.2%) |
| Sep 2020 | - | -$9.23 M(-61.1%) | -$66.45 M(-3.2%) |
| Jun 2020 | - | -$23.75 M(+24.2%) | -$68.66 M(+13.1%) |
| Mar 2020 | - | -$19.12 M(+33.2%) | -$60.72 M(+14.3%) |
| Dec 2019 | -$53.10 M | -$14.35 M(+25.4%) | -$53.10 M(+0.5%) |
| Sep 2019 | - | -$11.44 M(-27.7%) | -$52.83 M(-7.0%) |
| Jun 2019 | - | -$15.82 M(+37.6%) | -$56.80 M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$11.50 M(-18.3%) | -$58.99 M(-6.2%) |
| Dec 2018 | -$62.87 M(-0.8%) | -$14.07 M(-8.7%) | -$62.87 M(-7.3%) |
| Sep 2018 | - | -$15.41 M(-14.5%) | -$67.80 M(+1.8%) |
| Jun 2018 | - | -$18.02 M(+17.2%) | -$66.61 M(+4.0%) |
| Mar 2018 | - | -$15.37 M(-19.1%) | -$64.08 M(+1.1%) |
| Dec 2017 | -$63.37 M(+85.5%) | -$19.00 M(+33.6%) | -$63.37 M(+9.5%) |
| Sep 2017 | - | -$14.23 M(-8.1%) | -$57.87 M(+13.7%) |
| Jun 2017 | - | -$15.48 M(+5.6%) | -$50.88 M(+21.6%) |
| Mar 2017 | - | -$14.66 M(+8.6%) | -$41.83 M(+22.5%) |
| Dec 2016 | -$34.16 M(+47.3%) | -$13.50 M(+86.6%) | -$34.16 M(+25.5%) |
| Sep 2016 | - | -$7.24 M(+12.6%) | -$27.22 M(+8.2%) |
| Jun 2016 | - | -$6.43 M(-8.0%) | -$25.15 M(+1.4%) |
| Mar 2016 | - | -$6.99 M(+6.4%) | -$24.81 M(+7.0%) |
| Dec 2015 | -$23.18 M(+102.2%) | -$6.57 M(+27.0%) | -$23.18 M(+39.5%) |
| Sep 2015 | - | -$5.17 M(-15.0%) | -$16.62 M(+45.2%) |
| Jun 2015 | - | -$6.08 M(+13.5%) | -$11.45 M(+113.5%) |
| Mar 2015 | - | -$5.36 M | -$5.36 M |
| Dec 2014 | -$11.46 M | - | - |
FAQ
- What is Selecta Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Selecta Biosciences?
- What is Selecta Biosciences annual EBITDA year-on-year change?
- What is Selecta Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Selecta Biosciences?
- What is Selecta Biosciences quarterly EBITDA year-on-year change?
- What is Selecta Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Selecta Biosciences?
- What is Selecta Biosciences TTM EBITDA year-on-year change?
What is Selecta Biosciences annual EBITDA?
The current annual EBITDA of SELB is $39.09 M
What is the all time high annual EBITDA for Selecta Biosciences?
Selecta Biosciences all-time high annual EBITDA is $39.09 M
What is Selecta Biosciences annual EBITDA year-on-year change?
Over the past year, SELB annual EBITDA has changed by +$44.71 M (+794.90%)
What is Selecta Biosciences quarterly EBITDA?
The current quarterly EBITDA of SELB is -$12.62 M
What is the all time high quarterly EBITDA for Selecta Biosciences?
Selecta Biosciences all-time high quarterly EBITDA is $29.84 M
What is Selecta Biosciences quarterly EBITDA year-on-year change?
Over the past year, SELB quarterly EBITDA has changed by -$5.56 M (-78.75%)
What is Selecta Biosciences TTM EBITDA?
The current TTM EBITDA of SELB is -$37.08 M
What is the all time high TTM EBITDA for Selecta Biosciences?
Selecta Biosciences all-time high TTM EBITDA is $51.97 M
What is Selecta Biosciences TTM EBITDA year-on-year change?
Over the past year, SELB TTM EBITDA has changed by -$83.00 M (-180.74%)